Literature DB >> 10966850

Hereditary breast cancer: a review.

B Arver1, Q Du, J Chen, L Luo, A Lindblom.   

Abstract

Breast cancer is the most common female malignancy and a major cause of death in middle-aged women. A positive family history of breast cancer is one of the strongest risk factors for the disease. In addition, many afflicted breast cancer families are characterized by early onset and bilateral tumors, and also, in some cases, associated malignancies, most commonly ovarian cancer. It is estimated that 5-10% of all breast cancer cases are due to autosomal dominant genes segregating with the disease. Mutations in the BRCA1 and BRCA2 genes are known to predispose to breast and ovarian cancer in many families. Other genes are only involved in very rare syndromes, and additional genes remain to be disclosed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966850     DOI: 10.1006/scbi.2000.0325

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  11 in total

1.  Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population.

Authors:  M Atri; E Jafarimojarrad; M Javidroozi; P Mehdipour
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 2.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

3.  Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database.

Authors:  Justo Lorenzo Bermejo; Alfonso García Pérez; Kari Hemminki
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

4.  Birth characteristics and childhood carcinomas.

Authors:  K J Johnson; S E Carozza; E J Chow; E E Fox; S Horel; C C McLaughlin; B A Mueller; S E Puumala; P Reynolds; J Von Behren; L G Spector
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

5.  Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Authors:  Valgerdur Birgisdottir; Olafur A Stefansson; Sigridur K Bodvarsdottir; Holmfridur Hilmarsdottir; Jon G Jonasson; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

6.  Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.

Authors:  I Soerjomataram; W J Louwman; M J C van der Sangen; R M H Roumen; J W W Coebergh
Journal:  Br J Cancer       Date:  2006-06-27       Impact factor: 7.640

7.  The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.

Authors:  Nisreen Al-Moghrabi; Asmaa Nofel; Nujoud Al-Yousef; Safia Madkhali; Suad M Bin Amer; Ayodele Alaiya; Zakia Shinwari; Taher Al-Tweigeri; Bedri Karakas; Asma Tulbah; Abdelilah Aboussekhra
Journal:  BMC Cancer       Date:  2014-11-17       Impact factor: 4.430

8.  Identifying a BRCA2 c.5722_5723del mutation in a Han-Chinese family with breast cancer.

Authors:  Yi Guo; Peng Wang; Xiaorong Li; Shaihong Zhu; Hongbo Xu; Shizhou Li; Hao Deng; Lamei Yuan
Journal:  Biosci Rep       Date:  2019-04-30       Impact factor: 3.840

9.  Possible DNA viral factors of human breast cancer.

Authors:  Chun-Ru Hsu; Tsong-Ming Lu; Lengsu William Chin; Chi-Chiang Yang
Journal:  Cancers (Basel)       Date:  2010-04-13       Impact factor: 6.639

10.  Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA.

Authors:  Sarah L Daniels; George J Burghel; Philip Chambers; Shadi Al-Baba; Daniel D Connley; Ian W Brock; Helen E Cramp; Olena Dotsenko; Octavia Wilks; Lynda Wyld; Simon S Cross; Angela Cox
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.